Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors
Abstract:
Progression of premalignant lesions is restrained by oncogene-induced senescence. Oncogenic Ras triggers senescence in many organs, including the lung, which exhibits high levels of the angiogenesis inhibitor thrombospondin-1 (TSP-1). The contribution of TSP-1 upregulation to the modulation of tumorigenesis in the lung is unclear. Using a mouse model of lung cancer, we have shown that TSP-1 plays a critical and cell-autonomous role in suppressing Kras-induced lung tumorigenesis independent of its antiangiogenic function. Overall survival was decreased in a Kras-driven mouse model of lung cancer on a Tsp-1-/- background. We found that oncogenic Kras-induced TSP-1 upregulation in a p53-dependent manner. TSP-1 functioned in a positive feedback loop to stabilize p53 by interacting directly with activated ERK. TSP-1 tethering of ERK in the cytoplasm promoted a level of MAPK signaling that was sufficient to sustain p53 expression and a senescence response. Our data identify TSP-1 as a p53 target that contributes to maintaining Ras-induced senescence in the lung.
Insights
Thrombospondin-1 (TSP-1) restrains lung cancer progression by stabilizing p53 and promoting senescence, independent of its antiangiogenic effects. Loss of TSP-1 reduced survival in a Kras-driven lung cancer model.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Premalignant lesion progression is inhibited by oncogene-induced senescence.
- Oncogenic Ras activation triggers senescence in various organs, including the lung.
- Thrombospondin-1 (TSP-1), an angiogenesis inhibitor, is upregulated in the lung, but its role in tumorigenesis is unclear.
Purpose of the Study:
- To investigate the role of TSP-1 in Kras-induced lung tumorigenesis.
- To determine if TSP-1's function is linked to its antiangiogenic properties.
- To elucidate the molecular mechanisms by which TSP-1 influences senescence and tumor suppression.
Main Methods:
- Utilized a Kras-driven mouse model of lung cancer.
- Compared tumor progression and survival in wild-type and Tsp-1 knockout mice.
- Investigated the relationship between Kras, TSP-1, p53, ERK, and senescence pathways.
Main Results:
- TSP-1 plays a critical, cell-autonomous role in suppressing Kras-induced lung tumorigenesis, independent of antiangiogenesis.
- Mice lacking Tsp-1 exhibited decreased survival in a Kras-driven lung cancer model.
- Oncogenic Kras upregulates TSP-1 in a p53-dependent manner.
- TSP-1 stabilizes p53 by interacting with activated ERK, sustaining MAPK signaling and senescence.
Conclusions:
- TSP-1 is a p53 target that maintains Ras-induced senescence in the lung.
- TSP-1 acts as a tumor suppressor in Kras-driven lung cancer.
- The findings reveal a novel feedback loop involving TSP-1, p53, and ERK in senescence regulation.
More Related Videos
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
08:57Evaluating the Effect of SASP Factors on the Proliferation of Cancer Cells Using a Comparative Analysis of Three Distinct Methodologies
Published on: September 19, 2025
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
Replicative Cell Senescence
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
